EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Severe COVID-19 infection: An institutional review and literature overview

Ogheneyoma Akpoviroro iD, Nathan Kyle Sauers, Queeneth Uwandu, Myriam Castagne, Oghenetejiro Princess Akpoviroro, Sara Humayun, Wasique Mirza, Jameson Woodard

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0304960 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PLOS ONE, 2024. Verfasst von Ogheneyoma Akpoviroro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Geisinger Wyoming Valley Medical Center, Wilkes-Barre, Pennsylvania, United States of America. Hauptthemen laut MEDLINE: COVID-19, Hospital Mortality, Comorbidity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 207 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Our study aimed to describe the group of severe COVID-19 patients at an institutional level, and determine factors associated with different outcomes.

Methods

A retrospective chart review of patients admitted with severe acute hypoxic respiratory failure due to COVID-19 infection. Based on outcomes, we categorized 3 groups of severe COVID-19: (1) Favorable outcome: progressive care unit admission and discharge (2) Intermediate outcome: ICU care (3) Poor outcome: in-hospital mortality.

Results

Eighty-nine patients met our inclusion criteria; 42.7% were female. The average age was 59.7 (standard deviation (SD):13.7). Most of the population were Caucasian (95.5%) and non-Hispanic (91.0%). Age, sex, race, and ethnicity were similar between outcome groups. Medicare and Medicaid patients accounted for 62.9%. The average BMI was 33.5 (SD:8.2). Moderate comorbidity was observed, with an average Charlson Comorbidity index (CCI) of 3.8 (SD:2.6). There were no differences in the average CCI between groups(p = 0.291). Many patients (67.4%) had hypertension, diabetes (42.7%) and chronic lung disease (32.6%). A statistical difference was found when chronic lung disease was evaluated; p = 0.002. The prevalence of chronic lung disease was 19.6%, 27.8%, and 40% in the favorable, intermediate, and poor outcome groups, respectively. Smoking history was associated with poor outcomes (p = 0.04). Only 7.9% were fully vaccinated. Almost half (46.1%) were intubated and mechanically ventilated. Patients spent an average of 12.1 days ventilated (SD:8.5), with an average of 6.0 days from admission to ventilation (SD:5.1). The intermediate group had a shorter average interval from admission to ventilator (77.2 hours, SD:67.6), than the poor group (212.8 hours, SD:126.8); (p = 0.001). The presence of bacterial pneumonia was greatest in the intermediate group (72.2%), compared to the favorable group (17.4%), and the poor group (56%); this was significant (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Hospital MortalityComorbidityHumansMaleFemaleMiddle AgedAgedRetrospective StudiesSARS-CoV-2Intensive Care UnitsSeverity of Illness IndexRespiration, ArtificialHospitalizationRisk Factors

Autor:innen und Institutionen

  • Department of Internal Medicine, Geisinger Wyoming Valley Medical Center, Wilkes-Barre, Pennsylvania, United States of America.
  • Department of Engineering, Pennsylvania State University, State College, Pennsylvania, United States of America.
  • Clinical & Translational Science Institute, Boston University, Boston, Massachusetts, United States of America.
  • Department of Medicine, Mater Dei Hospital, Msida, Malta.

ORCID-Profile: Ogheneyoma Akpoviroro

Zitieren

APA

Akpoviroro, O., Sauers, N. K., Uwandu, Q., Castagne, M., Akpoviroro, O. P., Humayun, S., Mirza, W., & Woodard, J. (2024). Severe COVID-19 infection: An institutional review and literature overview. PLOS ONE. https://doi.org/10.1371/journal.pone.0304960

Vancouver

Akpoviroro O, Sauers NK, Uwandu Q, Castagne M, Akpoviroro OP, Humayun S, et al. Severe COVID-19 infection: An institutional review and literature overview. PLOS ONE. 2024. doi:10.1371/journal.pone.0304960

BibTeX
@article{Akpoviroro2024,
  author = {Akpoviroro, Ogheneyoma and Sauers, Nathan Kyle and Uwandu, Queeneth and Castagne, Myriam and Akpoviroro, Oghenetejiro Princess and Humayun, Sara and Mirza, Wasique and Woodard, Jameson},
  title = {Severe COVID-19 infection: An institutional review and literature overview},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0304960}
}
Kostenlos starten →